These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17334017)

  • 1. Nevirapine-induced fulminant hepatitis.
    Maniar JK; Shah SR; Verma R; Kamath R; Gupte P; Maniar A
    J Assoc Physicians India; 2006 Dec; 54():957-8. PubMed ID: 17334017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for fulminant hepatitis related to nevirapine therapy.
    Buyse S; Vibert E; Sebagh M; Antonini T; Ichai P; Castaing D; Samuel D; Duclos-Vallée JC
    Liver Transpl; 2006 Dec; 12(12):1880-2. PubMed ID: 17133571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.
    Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Chottanapund S; Mankatitham W; Chimsuntorn S; Sittibusaya C; Moolasart V; Chaovavanich A
    J Med Assoc Thai; 2008 Feb; 91(2):159-65. PubMed ID: 18389979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women.
    Phanuphak N; Apornpong T; Teeratakulpisarn S; Chaithongwongwatthana S; Taweepolcharoen C; Mangclaviraj S; Limpongsanurak S; Jadwattanakul T; Eiamapichart P; Luesomboon W; Apisarnthanarak A; Kamudhamas A; Tangsathapornpong A; Vitavasiri C; Singhakowinta N; Attakornwattana V; Kriengsinyot R; Methajittiphun P; Chunloy K; Preetiyathorn W; Aumchantr T; Toro P; Abrams EJ; El-Sadr W; Phanuphak P
    HIV Med; 2007 Sep; 8(6):357-66. PubMed ID: 17661843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
    Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Chantratita W; Nakamura Y
    Pharmacogenet Genomics; 2009 Feb; 19(2):139-46. PubMed ID: 19104471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic failure due to nevirapine treatment for HIV infection].
    Mens H; Katzenstein TL
    Ugeskr Laeger; 2005 Nov; 167(46):4359. PubMed ID: 16287519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal outcome of nevirapine-associated toxic epidermal necrolysis.
    Leng K; Lonsdorf A; Hartmann M
    Int J STD AIDS; 2008 Sep; 19(9):642-3. PubMed ID: 18725560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urgent liver transplantation for nevirapine-induced acute liver failure: report of a case and review of the literature.
    Lopez-Delgado JC; Mendiluce RM; Pinol TS; Fernández XP; Sanchez L; Vicente RG
    Ann Transplant; 2012; 17(1):122-7. PubMed ID: 22466918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for immune-mediated liver reactions by nevirapine revisited.
    Medrano J; Barreiro P; Tuma P; Vispo E; Labarga P; Blanco F; Soriano V
    AIDS Rev; 2008; 10(2):110-5. PubMed ID: 18615121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of acute hepatic failure during antituberculosis treatment: two cases and literature review.
    Smink F; van Hoek B; Ringers J; van Altena R; Arend SM
    Neth J Med; 2006 Nov; 64(10):377-84. PubMed ID: 17122456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced hepatotoxicity or drug-induced liver injury.
    Pugh AJ; Barve AJ; Falkner K; Patel M; McClain CJ
    Clin Liver Dis; 2009 May; 13(2):277-94. PubMed ID: 19442919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New nevirapine label underscores the risk for hepatotoxicity in key populations.
    AIDS Clin Care; 2004 Mar; 16(3):24. PubMed ID: 15119295
    [No Abstract]   [Full Text] [Related]  

  • 14. Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
    Thia TJ; Tan HH; Chuah TH; Chow WC; Lui HF
    Singapore Med J; 2008 Mar; 49(3):e86-9. PubMed ID: 18362995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.
    Manosuthi W; Kiertiburanakul S; Chaovavanich A; Sungkanuparph S
    J Med Assoc Thai; 2007 Feb; 90(2):244-50. PubMed ID: 17375627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment.
    de Maat MM; ter Heine R; van Gorp EC; Mulder JW; Mairuhu AT; Beijnen JH
    AIDS; 2003 Oct; 17(15):2209-14. PubMed ID: 14523278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimesulide-induced hepatotoxicity and fatal hepatic failure.
    Tan HH; Ong WM; Lai SH; Chow WC
    Singapore Med J; 2007 Jun; 48(6):582-5. PubMed ID: 17538762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral adverse effects due to the use of Nevirapine.
    Moura MD; Senna MI; Madureira DF; Fonseca LM; Mesquita RA
    J Contemp Dent Pract; 2008 Jan; 9(1):84-90. PubMed ID: 18176653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal fulminant hepatitis following administration of clarithromycin in a patient chronically treated with antipsycotic drugs.
    Maggi P; Solarino B; Cassano P; Tattoli L; Leone A; Maselli E; Angarano G
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):191-4. PubMed ID: 22804484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals.
    Vogel M; Bertram N; Wasmuth JC; Wyen C; Voigt E; Schwarze-Zander C; Sudhop T; Fätkenheuer G; Rockstroh JK; Reichel C
    J Antimicrob Chemother; 2009 May; 63(5):988-91. PubMed ID: 19270314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.